acquired immunity

(redirected from Adaptive immune system)
Also found in: Dictionary, Thesaurus, Medical, Acronyms, Wikipedia.
Related to Adaptive immune system: Innate immune system

acquired immunity

[ə′kwīrd ə′myün·ə·dē]
(immunology)
Resistance to a microbial or other antigenic substance taken on by a naturally susceptible individual; may be either active or passive.
References in periodicals archive ?
Placed near the first of several discussions on immunity, this laboratory can be used to introduce the innate immune system before moving to a discussion of the adaptive immune system.
Of perhaps greater interest is the link that TLRs provide between the innate and adaptive immune systems.
The innate immune system is responsible for providing a host with immediate protection from infection and the first line of signaling contributing to the activation of the adaptive immune system.
Along with providing initial defense against an infection, the innate immune system shapes the more targeted defense mounted by the adaptive immune system.
If not for the innate immune system, we'd be dead by the time the adaptive immune system raises antibodies to a pathogenic invader we have not encountered before.
Robins will discuss the Company's recent acquisition of Sequenta, and the combined company's vision to leverage the power of sequencing an individual's adaptive immune system to change the course of medicine.
Immunosequencing, which uses next generation sequencing tools to quantitatively characterize the adaptive immune system, represents a multi-billion dollar opportunity given the role the immune system plays in almost all areas of medicine.
MCT-475 is designed to activate the adaptive immune system to target unique structural motifs located on the surface of human metastatic colorectal cancer cells, while MCT-465 is designed to activate the innate immune system through TLR signaling.
2, 2014 /PRNewswire/ -- Adaptive Biotechnologies, the pioneer of Next Generation Sequencing (NGS) of the adaptive immune system, and its collaborators will present data demonstrating how immunosequencing can inform clinical care in patients with blood cancers at the American Society of Hematology (ASH) meeting from December 6-9, 2014.
The potency of the vaccine derives from the ability of flagellin to stimulate the innate immune system - a first line defense against pathogens, which in turn triggers a more potent response from the adaptive immune system, including the production of antibodies and cytotoxic ("killer") T cells.
29, 2014 /PRNewswire/ -- Adaptive Biotechnologies, a clinical stage diagnostics company that leverages Next Generation Sequencing to profile the adaptive immune system, announced today that it has established a Scientific Advisory Board to provide strategic and clinical guidance for the implementation of its clinical diagnostic suite of assays in the diagnosis and monitoring of patients with leukemia and lymphoma.
Flagellin is a toll-like receptor (TLR) ligand that stimulates the innate immune system - a first line defense against pathogens, which in turn triggers a more potent response from the adaptive immune system, including the production of antibodies and cytotoxic T cells.

Full browser ?